Page last updated: 2024-10-31

midazolam and Glycogen Storage Disease

midazolam has been researched along with Glycogen Storage Disease in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Djurberg, H1
Pothmann Facharzt, W1
Joseph, D1
Tjan, D1
Zuleika, M1
Ferns, S1
Rasheed, A1
Evans, DA1
Bassas, A1

Other Studies

1 other study available for midazolam and Glycogen Storage Disease

ArticleYear
Anesthesia care for living-related liver transplantation for infants and children with end-stage liver disease: report of our initial experience.
    Journal of clinical anesthesia, 2002, Volume: 14, Issue:8

    Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Intravenous; Atracurium; Biliary Atresia; Child; Child, Pr

2002